BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis.
Cancer Lett
; 412: 131-142, 2018 01 01.
Article
in En
| MEDLINE
| ID: mdl-28947136
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rhabdomyosarcoma
/
Apoptosis
/
Bcl-X Protein
/
Mitochondria
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Cancer Lett
Year:
2018
Document type:
Article
Affiliation country:
Germany
Country of publication:
Ireland